Annual Total Liabilities
$823.03 M
+$204.76 M+33.12%
December 31, 2023
Summary
- As of February 7, 2025, CHRS annual total liabilities is $823.03 million, with the most recent change of +$204.76 million (+33.12%) on December 31, 2023.
- During the last 3 years, CHRS annual total liabilities has risen by +$262.35 million (+46.79%).
- CHRS annual total liabilities is now at all-time high.
Performance
CHRS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$592.97 M
-$165.99 M-21.87%
September 30, 2024
Summary
- As of February 7, 2025, CHRS quarterly total liabilities is $592.97 million, with the most recent change of -$165.99 million (-21.87%) on September 30, 2024.
- Over the past year, CHRS quarterly total liabilities has dropped by -$124.41 million (-17.34%).
- CHRS quarterly total liabilities is now -29.86% below its all-time high of $845.39 million, reached on March 31, 2024.
Performance
CHRS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CHRS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.1% | -17.3% |
| 3 y3 years | +46.8% | -8.0% |
| 5 y5 years | +496.1% | -8.0% |
CHRS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +41.5% | -29.9% | +4.3% |
| 5 y | 5-year | at high | +171.0% | -29.9% | +95.2% |
| alltime | all time | at high | +4646.1% | -29.9% | +560.1% |
Coherus BioSciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $592.97 M(-21.9%) |
| Jun 2024 | - | $758.96 M(-10.2%) |
| Mar 2024 | - | $845.39 M(+2.7%) |
| Dec 2023 | $823.03 M(+33.1%) | $823.03 M(+14.7%) |
| Sep 2023 | - | $717.38 M(+11.3%) |
| Jun 2023 | - | $644.36 M(+7.6%) |
| Mar 2023 | - | $598.93 M(-3.1%) |
| Dec 2022 | $618.26 M(+6.3%) | $618.26 M(-4.6%) |
| Sep 2022 | - | $648.04 M(+14.0%) |
| Jun 2022 | - | $568.63 M(-2.1%) |
| Mar 2022 | - | $580.82 M(-0.1%) |
| Dec 2021 | $581.61 M(+3.7%) | $581.61 M(-4.8%) |
| Sep 2021 | - | $610.97 M(+4.7%) |
| Jun 2021 | - | $583.32 M(+3.1%) |
| Mar 2021 | - | $565.63 M(+0.9%) |
| Dec 2020 | $560.67 M(+84.6%) | $560.67 M(+2.3%) |
| Sep 2020 | - | $548.00 M(+0.9%) |
| Jun 2020 | - | $543.23 M(+75.7%) |
| Mar 2020 | - | $309.26 M(+1.8%) |
| Dec 2019 | $303.71 M | $303.71 M(+11.9%) |
| Sep 2019 | - | $271.36 M(+11.0%) |
| Jun 2019 | - | $244.44 M(+8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $224.63 M(+62.7%) |
| Dec 2018 | $138.06 M(+4.5%) | $138.06 M(+7.0%) |
| Sep 2018 | - | $129.07 M(+2.0%) |
| Jun 2018 | - | $126.48 M(-3.9%) |
| Mar 2018 | - | $131.55 M(-0.4%) |
| Dec 2017 | $132.08 M(-17.0%) | $132.08 M(-2.1%) |
| Sep 2017 | - | $134.85 M(-4.6%) |
| Jun 2017 | - | $141.39 M(-6.1%) |
| Mar 2017 | - | $150.54 M(-5.4%) |
| Dec 2016 | $159.13 M(-27.4%) | $159.13 M(-0.9%) |
| Sep 2016 | - | $160.63 M(-48.7%) |
| Jun 2016 | - | $313.05 M(+6.8%) |
| Mar 2016 | - | $293.11 M(+33.7%) |
| Dec 2015 | $219.31 M(+82.1%) | $219.31 M(+35.2%) |
| Sep 2015 | - | $162.27 M(+5.9%) |
| Jun 2015 | - | $153.18 M(+33.0%) |
| Mar 2015 | - | $115.16 M(-4.4%) |
| Dec 2014 | $120.46 M(+34.1%) | $120.46 M(+0.4%) |
| Sep 2014 | - | $120.00 M(+11.5%) |
| Jun 2014 | - | $107.61 M(+19.8%) |
| Dec 2013 | $89.83 M(+418.0%) | $89.83 M |
| Dec 2012 | $17.34 M | - |
FAQ
- What is Coherus BioSciences annual total liabilities?
- What is the all time high annual total liabilities for Coherus BioSciences?
- What is Coherus BioSciences annual total liabilities year-on-year change?
- What is Coherus BioSciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Coherus BioSciences?
- What is Coherus BioSciences quarterly total liabilities year-on-year change?
What is Coherus BioSciences annual total liabilities?
The current annual total liabilities of CHRS is $823.03 M
What is the all time high annual total liabilities for Coherus BioSciences?
Coherus BioSciences all-time high annual total liabilities is $823.03 M
What is Coherus BioSciences annual total liabilities year-on-year change?
Over the past year, CHRS annual total liabilities has changed by +$204.76 M (+33.12%)
What is Coherus BioSciences quarterly total liabilities?
The current quarterly total liabilities of CHRS is $592.97 M
What is the all time high quarterly total liabilities for Coherus BioSciences?
Coherus BioSciences all-time high quarterly total liabilities is $845.39 M
What is Coherus BioSciences quarterly total liabilities year-on-year change?
Over the past year, CHRS quarterly total liabilities has changed by -$124.41 M (-17.34%)